Biomarker News and Research

RSS

A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.

New approach to quantify tumor-specific total mRNA levels from patient tumor samples

Researchers at The University of Texas MD Anderson Cancer Center have developed a new approach to quantify tumor-specific total mRNA levels from patient tumor samples, which contain both cancer and non-cancer cells.

14 Jun 2022

Discovery could lead to a simple screening process for predicting heart attack risk

Combining information about the pattern of blood vessels in the retina with genetic data can enable accurate prediction of an individual's risk of coronary artery disease (CAD) and its potentially fatal outcome, myocardial infarction (MI), commonly known as a heart attack.

13 Jun 2022

USA–Japan Workshop participants present cutting-edge research on biomarkers for early detection of cancer

Successful treatment of cancer frequently depends on early detection. However, many cancers are detected late, often after metastasizing to other sites.

9 Jun 2022

Cognitive impairment and function in SARS-CoV-2 positive patients

Researchers assessed the association between post-acute COVID-19 cognitive impairment and kynurenine pathway activation.

9 Jun 2022

Research suggests two protein coding genes can predict severe COVID-19

In a recent study posted to the medRxiv* pre-print server, researchers demonstrated that two genes, GTPase, IMAP Family Member 7 (GIMAP7), and sphingosine-1-phosphate receptor 2 (S1PR2), have the potential to predict severe coronavirus disease 2019 (COVID-19) with ~90% accuracy.

8 Jun 2022

New technology may enable rapid diagnosis of Ebola virus

A new tool can quickly and reliably identify the presence of Ebola virus in blood samples, according to a study by researchers at Washington University School of Medicine in St. Louis and colleagues at other institutions.

8 Jun 2022

Open multiplexing with Cell DIVE offers cancer researchers more choices

Leica has introduced a new generation of its multiplexed imaging solution, Cell DIVE, including software and hardware improvements. The more scalable and efficient multiplexing platform addresses spatial cell biology and function within the tissue microenvironment

From Leica Microsystems GmbH 8 Jun 2022

Irregularities in production of brain cells may lead to autism spectrum disorder, finds study

Analyzing brain stem cells of patients with autism spectrum disorder (ASD), Rutgers scientists have found evidence of irregularities in very early brain development that may contribute to the neuropsychiatric disorder.

8 Jun 2022

Study identifies some breast cancer patients who can avoid radiotherapy

Older women with early-stage breast cancer may not need radiotherapy after undergoing surgery, McMaster University researcher Timothy Whelan and his team has found.

7 Jun 2022

Liquid biopsy could better predict immunotherapy response in lung cancer patients than tumor biopsy

Mount Sinai researchers have validated for the first time that a simple blood test called a liquid biopsy could be a better predictor of whether cancer immunotherapy will be successful for a patient with lung cancer than an invasive tumor biopsy procedure.

3 Jun 2022

Benefits and limitations of non-invasive tests for diagnosing non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is among the most prevalent chronic liver disorders worldwide and can sometimes lead to severe conditions like cirrhosis and hepatocellular carcinoma.

2 Jun 2022

New SOL-INCA-AD grant extends the initial study to examine cognitive aging among Latinos

Researchers at University of California San Diego School of Medicine have received a $24.5 million grant from the National Institutes of Health (NIH)/National Institute on Aging (NIA) to continue the Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA), a 12-year assessment of cognitive and brain aging and impairment among aging Latinos.

1 Jun 2022

Scientists determine trajectory and pathophysiology of post-COVID-19 syndrome

A new study utilizes multisystem imaging, along with biomarker analysis, to better understand the pathogenesis of COVID-19.

30 May 2022

New biomarker may enable rapid, inexpensive diagnosis of Parkinson's disease

Researchers at Kobe University and Hiroshima University have successfully developed a biomarker that will enable Parkinson's disease to be rapidly and inexpensively diagnosed from blood serum samples.

26 May 2022

New initiative aims to increase collaboration and accelerate high-impact cancer immunotherapy

The accelerated advancement of cancer immunology and immunotherapy, a type of biological therapy that boosts the immune system's ability to recognize and kill cancer cells, has significantly improved the effectiveness of cancer treatment and patient outcomes.

25 May 2022

Robust biomarker panel could help predict gestational diabetes in early pregnancy

UCLA researchers have taken the initial step in identifying what may be an effective way to detect gestational diabetes mellitus (GDM) earlier in pregnancy, potentially improving diagnosis and treatment for what is the most common disorder of pregnancy.

25 May 2022

Biomarker News and Research

Further Reading

New approach to quantify tumor-specific total mRNA levels from patient tumor samples

Discovery could lead to a simple screening process for predicting heart attack risk

USA–Japan Workshop participants present cutting-edge research on biomarkers for early detection of cancer

Cognitive impairment and function in SARS-CoV-2 positive patients

Research suggests two protein coding genes can predict severe COVID-19

New technology may enable rapid diagnosis of Ebola virus

Open multiplexing with Cell DIVE offers cancer researchers more choices

Irregularities in production of brain cells may lead to autism spectrum disorder, finds study

Study identifies some breast cancer patients who can avoid radiotherapy

Liquid biopsy could better predict immunotherapy response in lung cancer patients than tumor biopsy

Benefits and limitations of non-invasive tests for diagnosing non-alcoholic fatty liver disease

New SOL-INCA-AD grant extends the initial study to examine cognitive aging among Latinos

Scientists determine trajectory and pathophysiology of post-COVID-19 syndrome

New biomarker may enable rapid, inexpensive diagnosis of Parkinson's disease

New initiative aims to increase collaboration and accelerate high-impact cancer immunotherapy

Robust biomarker panel could help predict gestational diabetes in early pregnancy

Epigenetic markers associated with different risks of developing complications in type 2 diabetes

Serological biomarker predicts severe Crohn's disease seven years prior to diagnosis

'Crown-like structures' surrounding breast tumors could hinder treatment response, study finds

Blood-based biomarker can predict the benefit of immunotherapy to lung cancer patients

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo